What is the direct cause of death from lymphoma

The mortality rate of lymphoma is high, but the symptoms of the disease are easy to detect. Let me tell you what is the direct cause of death from lymphoma? What is the prognosis if it is treated? Many lymphoma patients show painless cervical lymph node enlargement in the early stage, which continues to grow. Later, other parts such as submandibular and axillary lymph nodes will also be discovered one after another. So what are the causes of death from this disease?

1. Cancer cell classification: How long a person can live is related to the "good" or "bad" nature of the tumor cells, the growth rate of the tumor, the speed of metastasis, and the effect of treatment. Why do cancers of the same organ have different treatment outcomes and different life spans? The pathological type of the tumor cells is one of the determining factors.

2. Treatment: For patients in the advanced stage, "giving up treatment" or "over-treatment" are both foolish choices. Therefore, choosing the right treatment method has a great impact on the quality of life during survival.

3. Patient's physical condition: The physical condition depends on the effect of treatment and the degree of toxic side effects caused by treatment. Maintaining a good attitude has a great impact on the treatment effect, which naturally affects the survival period.

Lymphoma is divided into Hodgkin lymphoma and non-Hodgkin lymphoma, and the two types have different prognostic measures.

The prognosis of Hodgkin's lymphoma is closely related to the tissue type and clinical stage. The 5-year survival rate of Hodgkin's lymphoma is 92.5% in stage I, 86.3% in stage II, 69.5% in stage III, and 31.9% in stage IV. Systemic symptoms are worse than those without. Children and the elderly generally have a worse prognosis than young and middle-aged people; women have better prognosis after treatment than men.

The prognosis of non-Hodgkin's lymphoma is equally important to the pathological type and stage. The presence or absence of systemic symptoms has less impact on the prognosis than HL. If the low-grade malignant group is discovered early, it can have a survival period of 5 to 10 years or even longer with reasonable treatment. Some highly malignant lymphomas are sensitive to radiotherapy and chemotherapy, and with reasonable treatment, the survival period can also be significantly extended.

Lymphoma is a malignant tumor with high morbidity and mortality in clinical practice, and patients should actively receive treatment.